BENZATHINE BENZYLPENICILLIN, 2.4 MIU, powder, vial + solvent
STD
DINJPENB2VS
Valid Article
Account code:
60000
HS Code:
300410
Last Updated on:
02/05/2024, 22:44:37
6.2.1 - Access group antibiotics
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
J01CE08
Anatomical Therapeutic Chemical Classification according to WHOCC
OC subscriptions: included in supply or field order tools (e.g. UniField)
|
|
SC subscriptions: included in supply or field tools
|
|
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)
|
|
BENZATHINE BENZYLPENICILLIN
Therapeutic Action
Long-acting penicillin antibacterial (15-20 days)
Indications
Endemic treponematoses (yaws, bejel, pinta)
Streptococcal tonsillitis
Prophylaxis of diphtheria in the event of direct contact
Primary and secondary prophylaxis of rheumatic fever
Instructions for use
- 1.2 MIU = 900 mg benzathine benzylpenicillin to be reconstituted with the diluent supplied (4 ml water for injection).
- 2.4 MIU = 1.8 g benzathine benzylpenicillin to be reconstituted with the diluent supplied (8 ml water for injection).
Must be given as IM injection only.
Precautions for Use
Never administer by IV route or infusion.
Do not confuse with short-acting benzylpenicillin (peni G), administered by IV route.
Storage
- Below 25°C - Protect from sunlight ‐ Protect from humidity
- After reconstitution, use the suspension immediately.
![[KMEDMHCM12-] (mod OPD) COMPLEMENTARY MEDICINES](/web/image/product.template/572689/image_256/%5BKMEDMHCM12-%5D%20%28mod%20OPD%29%20COMPLEMENTARY%20MEDICINES?unique=f108808)
![[KMEDMSUP05AA] (IEHK 2024 supplementary) MODULE INJECTABLE MEDICINES](/web/image/product.template/583191/image_256/%5BKMEDMSUP05AA%5D%20%28IEHK%202024%20supplementary%29%20MODULE%20INJECTABLE%20MEDICINES?unique=b9db92f)